Pharmasset, Inc. (Public, NASDAQ:VRUS)

[Michael Scally MD]

The premium is almost 100% to Friday close.

Gilead Sciences to Acquire Pharmasset, Inc. for $11 Billion
http://finance.yahoo.com/news/gilead-sciences-acquire-pharmasset-inc-120000407.html

ANYONE WHO INVESTED WITH THIS COMPANY WHEN THIS FORUM STARTED JUST MADE $$$$$$$$$$.